Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Philipp Douschan is active.

Publication


Featured researches published by Philipp Douschan.


European Respiratory Journal | 2016

CD133+ cells in pulmonary arterial hypertension.

Vasile Foris; Gabor Kovacs; Leigh M. Marsh; Zoltán Bálint; Martin Tötsch; Alexander Avian; Philipp Douschan; Bahil Ghanim; Walter Klepetko; Andrea Olschewski; Horst Olschewski

Circulating mononuclear cells may play an important role for the vascular remodelling in pulmonary arterial hypertension (PAH), but studies addressing multiple progenitor populations are rare and inconsistent. We used a comprehensive fluorescence-activated cell sorting analysis of circulating mononuclear cells in 20 PAH patients and 20 age- and sex-matched controls, and additionally analysed CD133+ cells in the lung tissue of five PAH transplant recipients and five healthy controls (donor lungs). PAH patients were characterised by increased numbers of circulating CD133+ cells and lymphopenia as compared with control. In PAH, CD133+ subpopulations positive for CD117 or CD45 were significantly increased, whereas CD133+CD309+, CD133+CXCR2+ and CD133+CD31+ cells were decreased. In CD133+ cells, SOX2, Nanog, Ki67 and CXCR4 were not detected, but Oct3/4 mRNA was present in both PAH and controls. In the lung tissue, CD133+ cells included three main populations: type 2 pneumocytes, monocytes and undifferentiated cells without significant differences between PAH and controls. In conclusion, circulating CD133+ progenitor cells are elevated in PAH and consist of phenotypically different subpopulations that may be up- or downregulated. This may explain the inconsistent results in the literature. CD133+ type 2 pneumocytes in the lung tissue are not associated with circulating CD133+ mononuclear cells. PAH patients are characterised by lymphopenia and increased numbers of CD133+ cells http://ow.ly/YNfQE


American Journal of Respiratory and Critical Care Medicine | 2017

Mild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality

Philipp Douschan; Gabor G. Kovacs; Alexander Avian; Vasile Foris; Fabian Gruber; Andrea Olschewski; Horst Olschewski

Rationale: Normal mean pulmonary arterial pressure (mPAP) is 14.0 ± 3.3 mm Hg (mean ± SD). The prognostic relevance of mildly elevated mPAP not fulfilling the definition of pulmonary hypertension (PH; mPAP ≥ 25 mm Hg) has not been prospectively evaluated in a real‐world setting. Objectives: To assess the association of resting mPAP with all‐cause mortality in a retrospective and a prospective cohort of patients with unexplained dyspnea and/or at risk of PH. Methods: Prognostic cutoffs were calculated by means of 1) classification and regression tree (CART) analysis without any preset thresholds, and 2) preset thresholds on the basis of literature data defining mPAP as lower‐normal (≤mean + 1 SD), upper‐normal (between mean + 1 SD and mean + 2 SD), borderline (between mean + 2 SD and 25 mm Hg), and manifest PH (≥25 mm Hg). We performed univariate and multivariate survival analysis adjusted for age and comorbidities. Measurements and Main Results: We enrolled 547 patients, of whom 137, 56, 64, and 290 presented with lower‐normal, upper‐normal, or borderline mPAP, and manifest PH, respectively. The CART analysis on mPAP discriminated three prognostic groups: mPAP less than 17 mm Hg, 17 to 26 mm Hg, and greater than 26 mm Hg, with significantly decreasing survival. The univariate analysis on the basis of preset thresholds showed that upper‐normal mPAP, borderline mPAP, and manifest PH were significantly associated with poor survival compared with lower‐normal mPAP. In the multivariate model, considering age and comorbidities, only borderline mPAP (hazard ratio, 2.37; 95% confidence interval, 1.14‐4.97; P = 0.022) and manifest PH (hazard ratio, 5.05; 95% confidence interval, 2.79‐9.12; P < 0.001) were significantly associated with poor survival. Conclusions: In patients at risk for PH and/or with unexplained dyspnea, CART analysis detects prognostic thresholds at a resting mPAP of 17 mm Hg and 26 mm Hg, and values between 20 mm Hg and 25 mm Hg represent an independent predictor of poor survival. Clinical trial registered with www.clinicaltrials.gov (NCT 01607502).


PLOS ONE | 2016

Use of ECG and Other Simple Non-Invasive Tools to Assess Pulmonary Hypertension.

Gabor G. Kovacs; Alexander Avian; Vasile Foris; Maria Tscherner; Xhylsime Kqiku; Philipp Douschan; Gerhard Bachmaier; Andrea Olschewski; Marco Matucci-Cerinic; Horst Olschewski

Background There is a broad consensus that pulmonary hypertension (PH) is to be diagnosed by right heart catheterization (RHC) and that the most important non-invasive tool is echocardiography. However, the role of simple non-invasive tools in the work-up of PH is not clearly defined. We hypothesized that the use of simple non-invasive techniques may help to guide important decisions in the diagnostics of pulmonary hypertension. Objectives We aimed to develop an algorithm with the use of simple, non-invasive tools in order to identify patients with very high or very low likelihood of PH. Methods We retrospectively analyzed all consecutive patients undergoing RHC between 2005 and 2010 in our center and performed logistic regression of simple non-invasive parameters regarding detection and exclusion of PH and derived a two-step algorithm. In a prospective study we evaluated this algorithm between 2011 and 2013. Results The retrospective cohort consisted of n = 394 patients of which 49% presented with PH. Right axis deviation in the ECG was present in 90/394 patients and had a positive predictive value (PPV) of 93% for PH. The combination of non-right axis deviation, N-terminal pro brain natriuretic peptide (NT-proBNP)<333pg/ml, arterial oxygen saturation (SO2)≥95.5% and WHO functional class I-II was present in 69/394 patients and excluded PH with a negative predictive value (NPV) of 96%. The prospective study confirmed these results in a cohort of n = 168 patients (PPV:92%, NPV:97%). Taken together, simple non-invasive tools allowed a prediction regarding the presence or absence of PH in 42% of patients with suspected PH. Conclusion ECG, NT-proBNP, SO2 and WHO functional class may predict the presence or absence of PH in almost half of the patients with suspected PH, suggesting an important role for these variables in the work-up of patients at risk for PH. Clinical Trial Registration NCT01607502


Liver International | 2017

Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosis

Ariane Aigelsreiter; Jens Neumann; Martin Pichler; Judith Halasz; Kurt Zatloukal; Andrea Berghold; Philipp Douschan; F. Rainer; Rudolf E. Stauber; Johannes Haybaeck; Helmut Denk; Carolin Lackner

Mallory‐Denk bodies (MDBs) and intracellular hyaline bodies (IHBs) are cytoplasmic inclusions found in a subset of hepatocellular carcinoma (HCC). MDBs are mainly composed of the intermediate filament proteins keratin (K) 8 and K18, the cellular stress‐ and adapter‐protein sequestosome 1/p62 (p62) and ubiquitin, whereas IHBs consist of p62 and/or ubiquitin. Of note, cytoplasmic inclusions containing p62 can serve as markers of suppressed autophagy, which in turn has been associated with poor prognosis. The aim of this study was to evaluate the prognostic significance of p62‐containing MDB and IHB in patients with HCC.


Journal of Hepatology | 2015

P0115 : Serum bile acids in cirrhosis depend on aetiology

A Horvath; Bettina Leber; Elisabeth Krones; Gernot Zollner; F Durchschein; Walter Spindelboeck; Sandra Lemesch; Philipp Douschan; Günter Fauler; Tatjana Stojakovic; Peter Fickert; Rudolf E. Stauber; Philipp Stiegler; Vanessa Stadlbauer

P0115 SERUM BILE ACIDS IN CIRRHOSIS DEPEND ON AETIOLOGY A. Horvath, B. Leber, E. Krones, G. Zollner, F. Durchschein, W. Spindelboeck, S. Lemesch, P. Douschan, G. Fauler, T. Stojakovic, P. Fickert, R. Stauber, P. Stiegler, V. Stadlbauer. Division for Gastroenterology and Hepatology, Department for Tranplantation Surgery, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria E-mail: [email protected]


Journal of Hepatology | 2017

Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease

Carolin Lackner; Walter Spindelboeck; Johannes Haybaeck; Philipp Douschan; F. Rainer; Luigi Terracciano; Josef Haas; Andrea Berghold; Ramon Bataller; Rudolf E. Stauber


Journal of Hepatology | 2013

244 INCREASED GUT PERMEABILITY, ELEVATED ENDOTOXIN RELATED PROTEINS AND NEUTROPHIL DYSFUNCTION IN LIVER CIRRHOSIS

A Horvath; Bettina Leber; Sandra Lemesch; Philipp Stiegler; Rudolf E. Stauber; Peter Fickert; Gernot Zollner; Walter Spindelboeck; Elisabeth Krones; F Durchschein; Philipp Douschan; Vanessa Stadlbauer


Zeitschrift Fur Gastroenterologie | 2018

Functional response of neutrophils is associated with serum bile acids profile in liver cirrhotic patients

I. Komarova; A Horvath; Elisabeth Krones; Bettina Leber; B. Schmerboeck; F Durchschein; Gernot Zollner; Rudolf E. Stauber; Walter Spindelboeck; Philipp Douschan; Philipp Stiegler; Daniela Kniepeiss; Tatjana Stojakovic; Günter Fauler; Peter Fickert; Vanessa Stadlbauer


Journal of Hepatology | 2018

Changes of bile acids profile in different etiologies of liver cirrhosis and its association with neutrophil response

I. Komarova; A Horvath; Elisabeth Krones; Bettina Leber; B. Schmerboeck; F Durchschein; Gernot Zollner; Rudolf E. Stauber; W. Spindelböck; Philipp Douschan; Philipp Stiegler; Daniela Kniepeiss; Tatjana Stojakovic; Günter Fauler; Vanessa Stadlbauer


Zeitschrift Fur Gastroenterologie | 2017

Limited value of clinical criteria for diagnosis of alcoholic steatohepatitis (ASH)

Rudolf E. Stauber; W Spindelböck; F Rainer; Philipp Douschan; C Lackner

Collaboration


Dive into the Philipp Douschan's collaboration.

Top Co-Authors

Avatar

Rudolf E. Stauber

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Horst Olschewski

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Gernot Zollner

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Elisabeth Krones

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Peter Fickert

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Andrea Olschewski

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Vasile Foris

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

F Durchschein

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge